Gapping down
In reaction to disappointing earnings/guidance: MZOR -7.2%.
Other news: ALNY -5.8% ( presents new pre-clinical data on RNAi Therapeutics for cardiovascular disease), FU -5.5% (continued volatility), CXP -2.5% (following late spike, announces final results of its modified Dutch Auction tender offer; total of ~9.362 mln shares of Common Stock were properly tendered and not properly withdrawn at or below the final purchase price of $25.00 per share), YOKU -2.4% and RENN -1.4% (still checking), QGEN -1.8% ( Announces Third Co-Development Program for Companion Diagnostics Paired With Lilly's (LLY) Investigational Cancer Compounds ; New partnership builds on Lilly-QIAGEN framework agreement), ADT -1.6% (unfavorable mention on MadMoney), UNH -0.4% ( plans to drop thousands of doctors from plans, according to reports).
Analyst comments: SVU -4.9% (downgraded to Sell from Neutral at Goldman), REGI -2.5% (downgraded to Hold from Buy at Canaccord Genuity), ANR -2.2% (downgraded to Sell from Neutral at Citigroup), NVDA -1.7% ( downgraded to Underweight from Equal-Weight at Morgan Stanley), MSFT -1.6% (downgraded to Underperform from Neutral at BofA/Merrill), WLT -0.8% (downgraded to Neutral from Buy at Citigroup), CNX -0.8% (downgraded to Neutral from Buy at Citigroup), HK -0.6% (downgraded to Sell from Neutral at Goldman)